世界卫生组织细胞病理学报告系统的开发与出版依据及肺和胰胆系统首版概述
国际细胞学会联合国际癌症研究机构和世界卫生组织开发了肺、胰胆等细胞病理学报告系统,近期发布了肺和胰胆系统报告系统。该系统旨在标准化报告、建立关键诊断特征、提供采样和处理最佳实践指南,并促进细胞病理学家与临床医生沟通。每个系统定义了特定类别和术语,并给出恶性肿瘤风险估计和诊断管理算法。
要点
- WHO细胞病理报告系统覆盖肺、胰胆等多个器官,已发布肺和胰胆系统。
- 每个报告类别提供基于文献的恶性肿瘤风险估计和诊断管理算法。
- 系统设计适用于全球不同资源环境,尤其考虑中低收入国家的基础设施差异。
核心结论
- 国际细胞学会、国际癌症研究机构和WHO合作开发细胞病理学报告系统,以标准化报告并改善患者照护。
- WHO已发布肺和胰胆系统细胞病理报告系统,每个类别附有恶性肿瘤风险估计和诊断管理算法。
研究设计与样本
- 本文为综述,介绍联合项目的原理和历史,并简要概述肺和胰胆系统报告系统。
- 编辑和作者选择及写作编辑责任采用与第五版WHO肿瘤分类相同的模型。
主要发现
- 合作目标包括标准化细胞病理报告、建立关键诊断细胞病理特征、提供采样和处理最佳实践指南、促进细胞病理学家与临床医生沟通。
- 每个WHO系统定义了特定报告类别和术语,每个类别在文献允许范围内给出恶性肿瘤风险估计和诊断管理算法建议。
- WHO系统考虑当地医疗和病理基础设施差异,尤其在中低收入国家,其建议设计为可在全球所有资源环境中应用。
临床怎么用
- 细胞病理学家可依据WHO系统标准化报告肺和胰胆细胞病理,并使用类别对应的恶性肿瘤风险和管理算法辅助临床决策。
- 在资源有限环境中,可参考WHO系统的适应性建议实施细胞病理报告。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The International Academy of Cytology has joined with the International Agency for Research on Cancer and the World Health Organization (WHO) to develop international systems for reporting the cytopathology of lung, pancreas and biliary tract, lymph nodes, soft tissue, liver, breast, and kidney and adrenal gland. The WHO recently published the reporting systems for lung and pancreaticobiliary cytopathology. The objectives of this collaboration are to standardize the reporting of cytopathology; improve the quality of reporting by establishing the key diagnostic cytopathological features of entities and neoplasms; provide detailed best-practice guidelines in sampling techniques, specimen handling and processing, and the use of ancillary techniques; and facilitate communication between cytopathologists and clinicians to improve patient care. Each WHO system has defined specific categories and terminology for reporting cytopathology, and each category has an estimated risk of malignancy as far as the current literature allows and a suggested diagnostic management algorithm to assist clinicians. The WHO systems recognize that local medical and pathology infrastructure will vary, particularly in low-income and middle-income countries, and the WHO systems and their diagnostic management recommendations have been developed to allow them to be applied worldwide in all resource settings. The process of the selection of editors and authors and the writing and editing responsibilities has used the same model as that used for the fifth edition WHO Classification of Tumours, to which the WHO cytopathology systems are directly linked. This review provides the rationale and history of this joint International Academy of Cytology, International Agency for Research on Cancer, and WHO cytopathology project and a brief overview of the WHO reporting systems for lung and pancreaticobiliary cytopathology.
引用
- Field AS, Pitman M, Cree IA, et al. The rationale for the development and publication of the World Health Organization reporting systems for cytopathology and a brief overview of the first editions of the lung and pancreaticobiliary systems. Cancer Cytopathol. 2023. PMID: 37702127. doi:10.1002/cncy.22757
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。